Reported Earlier, Veracyte Reports Preliminary FY2025 Revenue Of $515M–$517M Up ~16% YoY With Strong Testing Volume Growth, Q4 Revenue Of $138M–$140M And Introduces 2026 Revenue Outlook Of $570M–$582M

For the fourth quarter ended December 31, 2025, as compared to the same period of 2024, Veracyte expects to report:

• Total revenue of between $138 million and $140 million, an increase of between 16% and 18%
• Testing revenue of between $134 million and $136 million, an increase of between 19% and 21%
• Testing volume of approximately 45,500, an increase of 16%

For the full year ended December 31, 2025, as compared to the same period of 2024, Veracyte expects to report:

• Total revenue of between $515 million and $517 million, an increase of approximately 16%
• Testing revenue of between $491 million and $493 million, an increase of approximately 17% to 18%
• Testing volume of approximately 169,700, an increase of 19%
• Decipher volume of approximately 102,000, an increase of 27%, and Afirma volume of approximately 67,700, an increase of 11%